AnGes, GenoLac in HPV deal

AnGes MG Inc. (Tokyo:4563) and GenoLac BL Corp. (Okinawa, Japan) partnered to co-develop an HPV vaccine targeting E7 transforming protein (human papillomavirus-16; HpV16gp1). Details were not disclose...